Article
TP53 mutation, allelism and survival in non-small cell lung cancer.
Carcinogenesis - 1 Oct 2005
Nelson Heather H, Wilkojmen Magnus, Marsit Carmen J, Kelsey Karl T
Abstract excerpt
TP53 is well-recognized as a mutational target in cancers and common variation in the TP53 gene has been investigated as potentially contributing to cancer susceptibility. The codon 72 polymorphism has been proposed to alter the phenotype of TP53 mutations, and TP53 mutations have been reported to occur preferentially on the arginine allele. Using a consecutive case series of non-small cell lung cancer we have...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
